Global Life Science Analytics Market to Reach $66.7 Billion by 2030
The global market for Life Science Analytics estimated at US$24.4 Billion in the year 2022, is projected to reach a revised size of US$66.7 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2022-2030. Services, one of the segments analyzed in the report, is projected to record 14.2% CAGR and reach US$40.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Software segment is readjusted to a revised 12.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $7.1 Billion, While China is Forecast to Grow at 12.4% CAGR
The Life Science Analytics market in the U.S. is estimated at US$7.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.Select Competitors (Total 44 Featured) -
- Accenture PLC
- Cognizant Technology Solutions Corporation
- IBM Corporation
- IQVIA
- MaxisIT Inc.
- Oracle Corporation
- SAS Institute, Inc.
- SCIO Health Analytics, an EXL company
- TAKE Solutions
- Wipro Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 Pandemic & Looming Global Recession
- An Introduction to Life Science Analytics
- Global Market Prospects & Outlook
- Descriptive Analytics: The Largest Segment
- Sales & Marketing Application Poised for High Growth
- China & Asia-Pacific to Spearhead Future Market Growth
- Life Science Analytics - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
3. MARKET TRENDS & DRIVERS
- Technology Advancements Fuel Market Growth
- Rising Relevance of Big Data Analytics to Improve Productivity in Life Science Industry
- Analytics Solutions Find Increasing Adoption in Clinical Trials
- Rise in Pharmaceutical R&D Spending to Boost Adoption of Analytics in Clinical Research Institutions
- Pharmaceutical R&D Spending (in US$ Billion) for 2010-2020
- Leading Pharmaceutical Companies Ranked by R&D Spending
- AI, ML & Big Data Transform Clinical Trials Market
- Increasing Prevalence of Chronic Diseases Boosts Market Prospects
- Need to Curb Surging Healthcare Spending & Improve Patient Outcomes Enhance Importance of Analytics
- Growing Use of Analytics in Personalized and Precision Medicine: A Major Growth Opportunity
- Global Precision Medicine Market Size (US$ Billion) for the Years 2019, 2022 and 2025
- Need for Better Data Standardization Spurs Need for Analytics Solutions in Life Science Industry
- Rising Prominence of Value-Based Medicine Presents Opportunity for Market Growth
- High Implementation Costs, Privacy Concerns & Workforce Shortage: Key Challenges for the Market
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Life Science Analytics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 2: World Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 3: World 8-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 7: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 8: World Recent Past, Current & Future Analysis for Descriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 9: World 8-Year Perspective for Descriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Predictive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World 8-Year Perspective for Predictive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 12: World Recent Past, Current & Future Analysis for Prescriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 13: World 8-Year Perspective for Prescriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 14: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 15: World 8-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World 8-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 19: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 21: World 8-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Research Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 23: World 8-Year Perspective for Research Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 24: World Recent Past, Current & Future Analysis for Third-Party Administrators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 25: World 8-Year Perspective for Third-Party Administrators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
UNITED STATES
- Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 26: USA Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: USA 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 28: USA Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 29: USA 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 30: USA Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 31: USA 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 32: USA Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: USA 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
CANADA
- Table 34: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 35: Canada 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 36: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 37: Canada 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 38: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Canada 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 40: Canada Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 41: Canada 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
JAPAN
- Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 42: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 43: Japan 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 44: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Japan 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 46: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 47: Japan 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 48: Japan Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 49: Japan 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
CHINA
- Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 50: China Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: China 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 52: China Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 53: China 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 54: China Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 55: China 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 56: China Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: China 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
EUROPE
- Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 58: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 59: Europe 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 60: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 61: Europe 8-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- Table 62: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: Europe 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 64: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 65: Europe 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 66: Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 67: Europe 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
FRANCE
- Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 68: France Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: France 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 70: France Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 71: France 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 72: France Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 73: France 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 74: France Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: France 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
GERMANY
- Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 76: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 77: Germany 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 78: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 79: Germany 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 80: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: Germany 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 82: Germany Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 83: Germany 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
ITALY
- Table 84: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 85: Italy 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 86: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: Italy 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 88: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 89: Italy 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 90: Italy Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 91: Italy 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
UNITED KINGDOM
- Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 92: UK Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: UK 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 94: UK Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 95: UK 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 96: UK Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 97: UK 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 98: UK Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: UK 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
REST OF EUROPE
- Table 100: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 101: Rest of Europe 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 102: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 103: Rest of Europe 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 104: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 105: Rest of Europe 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 106: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 107: Rest of Europe 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
ASIA-PACIFIC
- Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 108: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 109: Asia-Pacific 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 110: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 111: Asia-Pacific 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 112: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 113: Asia-Pacific 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 114: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 115: Asia-Pacific 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
REST OF WORLD
- Table 116: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 117: Rest of World 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
- Table 118: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 119: Rest of World 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
- Table 120: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 121: Rest of World 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
- Table 122: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 123: Rest of World 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accenture PLC
- Cognizant Technology Solutions Corporation
- IBM Corporation
- IQVIA
- MaxisIT Inc.
- Oracle Corporation
- SAS Institute, Inc.
- SCIO Health Analytics, an EXL company
- TAKE Solutions
- Wipro Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 24.4 Billion |
| Forecasted Market Value ( USD | $ 66.7 Billion |
| Compound Annual Growth Rate | 13.4% |
| Regions Covered | Global |
